4//SEC Filing
Hall Brett Matthew 4
Accession 0001104659-21-099733
CIK 0001790340other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 6:05 AM ET
Size
10.6 KB
Accession
0001104659-21-099733
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
- Conversion
Series A Preferred Stock
2021-08-03−1,636→ 0 total→ Class A Common Stock (1,636 underlying) - Purchase
Class A Common Stock
2021-08-03$15.00/sh+1,353$20,295→ 6,393 total - Conversion
Series B Preferred Stock
2021-08-03−3,404→ 0 total→ Class A Common Stock (3,404 underlying) - Conversion
Class A Common Stock
2021-08-03+5,040→ 5,040 total
Footnotes (1)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870437
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 6:05 AM ET
- Size
- 10.6 KB